Redcliffe Labs adds ‘Novaseq 6000’ Sequencing System to its Diagnostic Technology Portfolio

New Delhi, 9^th June, 2022: Redcliffe Labs, a unit of Redcliffe Lifetech in the U.S., has announced the addition of ‘NovaSeq 6000’ sequencing system to their diagnostic technology portfolio at its Noida National Reference Lab.

India’s Diagnostics platform, Redcliffe is first in North India and among few in line in the country to line up the most advanced and high-end set of instruments. North India particularly is known to be very high in genetic disorders and is also characterized by consanguineous marriage which increases the chance of rare diseases. This finds vast application in the diagnosis of rare conditions in newborns, infants and in prenatal settings. While the system is being installed in the National lab, it serves the entire country with the most efficient logistics and will reduce the testing time and help save costs for the patients in the neighbouring region and states. Through its network of 700 collection centers and lab network across the country, Redcliffe is well-positioned to service the genetic testing requirements of the entire country including Tier 2 and 3 towns.

Ease of access to NovaSeq 6000 sequencing system will prove to be very useful, as currently there's no mass level testing protocol rolled out by the states for genetic diseases.

Commenting on the upcoming facility of NovaSeq 6000 sequencing system at Redcliffe Labs Noida, Dheeraj Jain, Founder, Redcliffe Labs said," The addition of the world's most advanced genome sequencing system for newborn and rare diseases will equip us to offer the most comprehensive suite of genetic testing services that find significant applications in rare and novel genetic variants."

Rare diseases are estimated to impact about 6% to 8% of the population in any given country. Even a conservative estimate of the country's population of 1.35 billion people results in a count of nearly 81 million people. Moreover, 70% of hereditary uncommon disorders manifest themselves in childhood.